|Alan Musso||Chief Financial Officer|
|Rick Fair||President and Chief Executive Officer|
|Bill Grossman||Chief Medical Officer|
|Jim Birchenough||Wells Fargo|
|Justin Kim||Cantor Fitzgerald|
|Pete Lawson||SunTrust Robinson Humphrey|
|Reni Benjamin||Raymond James|
Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to the Bellicum Pharmaceuticals Second Quarter 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time.